Pancreatic Cancer
Research Reports on Pancreatic Cancer from Capital Medical University Provide New Insights
Published in Gene Therapy Weekly, April 28th, 2011
2011 APR 28 -- Current study results from the report, 'Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression,' have been published. According to a study from Beijing, People's Republic of China, "The purpose of this study was to improve the gemcitabine sensitivity in pancreatic cancer by adenovirus-mediated co-regulation of dCK and p8 expression. Firstly, we analyzed the sensitivity of three human pancreatic tumor cell lines (Capan-2, Panc-1 and BxPc-3) to gemcitabine using MTT assays, and found Panc-1 to be relatively resistant to gemcitabine."
"Further, we investigated the expression of dCK and p8 in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-04-28)
More Articles from Gene Therapy Weekly
- Apoptosis
College of Medicine Details Research in Apoptosis - Colon Cancer
Data on Colon Cancer Described by Researchers at Shanghai Jiao Tong University - Osteosarcomas
Data on Osteosarcomas Reported by Researchers at Paterson Institute for Cancer Research - DNA Research
Findings from Adam Mickiewicz University Provide New Insights into DNA Research - GenVec, Inc.
GenVec Technology Used to Restore Lost Balance Function - Robotics
Health Robotics' CytoCare Enters Latin American Market in Partnership with Costa Rica's Pharmacy Leader Nutricare S.A. - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
